What ibogaine is—and isn’t—in Texas
Ibogaine is a psychoactive alkaloid extracted from the root bark of Tabernanthe iboga, used traditionally in Bwiti ceremonies in Central and West Africa. Pharmacologically, it acts across several systems—including serotonin transporters and receptors, NMDA receptors, and kappa-opioid receptors—producing an intense 12–24 hour psychedelic/dissociative experience. Clinical interest focuses on rapid reduction of opioid withdrawal symptoms and cravings, as well as potential impacts on PTSD, depression, and traumatic brain injury.
A basic botanical and historical description appears in Wikipedia’s ibogaine entry; that background does not alter the Texas distinction between research and lawful clinical availability.
In Texas, the scope is narrow: no legal prescribing or clinic use; research participation only. Texans seeking treatment commonly travel to jurisdictions where ibogaine is legal or unscheduled, for example clinics across the border in Mexico. For a neutral overview of the experience itself, see a community resource describing typical phases, timelines, and safety considerations.